KIR/KIR-ligand genotypes and clinical outcomes following chemoimmunotherapy in patients with relapsed or refractory neuroblastoma: a report from the Children’s Oncology Group
暂无分享,去创建一个
S. Servaes | A. Naranjo | J. Maris | S. Asgharzadeh | W. London | M. Diccianni | A. Yu | B. Shulkin | M. Parisi | R. Bagatell | Kyungeun Kim | Julie R. Park | P. Sondel | A. Erbe | J. Hung | R. Mody | Fan F Zhang | J. Birstler | A. Feils | Varsha Mathew